Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review
- PMID: 35325848
- PMCID: PMC8934717
- DOI: 10.1016/j.biopha.2022.112843
Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review
Abstract
The coronavirus disease 2019 (COVID-19) has overwhelming healthcare systems globally. To date, a myriad of therapeutic regimens has been employed in an attempt to curb the ramifications of a severe COVID-19 infection. Amidst the ongoing pandemic, the advent and efficacious uptake of COVID-19 vaccination has significantly reduced disease-related hospitalizations and mortality. Nevertheless, many side-effects are being reported after COVID-19 vaccinations and myocarditis is the most commonly reported sequelae post vaccination. Majority of these diseases are associated with COVID-19 mRNA vaccines. Various studies have established a temporal relationship between these complications, yet the causality and the underlying pathogenesis remain hypothetical. In this review, we aim to critically appraise the available literature regarding the cardiovascular side effects of the various mRNA vaccines and the associated pathophysiology.
Keywords: COVID-19 mRNA vaccine; COVID-19 myocarditis; COVID-19 perimyocarditis; Coronavirus 2019 (COVID-19); SARS-CoV-2; Takotsubo syndrome.
Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Figures



Similar articles
-
Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?Int J Infect Dis. 2022 Nov;124:1-10. doi: 10.1016/j.ijid.2022.08.026. Epub 2022 Sep 6. Int J Infect Dis. 2022. PMID: 36075372 Free PMC article. Review.
-
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.MMWR Morb Mortal Wkly Rep. 2022 Apr 8;71(14):517-523. doi: 10.15585/mmwr.mm7114e1. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35389977 Free PMC article.
-
Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.Circ J. 2022 Mar 25;86(4):724. doi: 10.1253/circj.CJ-21-0840. Epub 2021 Dec 4. Circ J. 2022. PMID: 34866122 No abstract available.
-
Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.JAMA Netw Open. 2022 Aug 1;5(8):e2226236. doi: 10.1001/jamanetworkopen.2022.26236. JAMA Netw Open. 2022. PMID: 35960521 Free PMC article.
-
The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination.Swiss Med Wkly. 2021 Oct 19;151:w30087. doi: 10.4414/smw.2021.w30087. eCollection 2021 Oct 11. Swiss Med Wkly. 2021. PMID: 34668687 Review.
Cited by
-
COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign.Cureus. 2024 Jan 24;16(1):e52876. doi: 10.7759/cureus.52876. eCollection 2024 Jan. Cureus. 2024. Retraction in: Cureus. 2024 Feb 26;16(2):r137. doi: 10.7759/cureus.r137. PMID: 38274635 Free PMC article. Retracted. Review.
-
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned?Int J Mol Sci. 2023 Jun 20;24(12):10405. doi: 10.3390/ijms241210405. Int J Mol Sci. 2023. PMID: 37373551 Free PMC article. Review.
-
Clinical rationale for dietary lutein supplementation in long COVID and mRNA vaccine injury syndromes.F1000Res. 2024 Oct 17;13:191. doi: 10.12688/f1000research.143517.3. eCollection 2024. F1000Res. 2024. PMID: 39526116 Free PMC article. Review.
-
Chronological Development of Cardiovascular Disease in Times of COVID-19: A Retrospective Analysis of Hospitalized Diseases of the Circulatory System and COVID-19 Patients of a German University Hospital.J Cardiovasc Dev Dis. 2022 Sep 25;9(10):325. doi: 10.3390/jcdd9100325. J Cardiovasc Dev Dis. 2022. PMID: 36286277 Free PMC article.
-
CMR Manifestations, Influencing Factors and Molecular Mechanism of Myocarditis Induced by COVID-19 Mrna Vaccine.Rev Cardiovasc Med. 2022 Oct 11;23(10):339. doi: 10.31083/j.rcm2310339. eCollection 2022 Oct. Rev Cardiovasc Med. 2022. PMID: 39077131 Free PMC article. Review.
References
-
- Ritchie H., Mathieu E., Rodés-Guirao L., 2021. et al. Coronavirus (COVID-19) vaccinations - statistics and research. Our World in Data. 〈https://ourworldindata.org/covid-vaccinations〉. Published March 5, 2020. Accessed 4 December 2021.
-
- Lopez Bernal J., Andrews N., Gower C., Gallagher E., Simmons R., Thelwall S., Stowe J., Tessier E., Groves N., Dabrera G., Myers R., Campbell C.N.J., Amirthalingam G., Edmunds M., Zambon M., Brown K.E., Hopkins S., Chand M., Ramsay M. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. N. Engl. J. Med. 2021;385(7):585–594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21. PMID: 34289274; PMCID: PMC8314739. - PMC - PubMed
-
- Eckart R.E., Love S.S., Atwood J.E., Arness M.K., Cassimatis D.C., Campbell C.L., Boyd S.Y., Murphy J.G., Swerdlow D.L., Collins L.C., Riddle J.R., Tornberg D.N., Grabenstein J.D., Engler R.J. Department of defense smallpox vaccination clinical evaluation team. incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. J. Am. Coll. Cardiol. 2004;44(1):201–205. doi: 10.1016/j.jacc.2004.05.004. PMID: 15234435. - PubMed
-
- Myocarditis and pericarditis after mrna COVID-19 vaccination. Centers for Disease Control and Prevention. 〈https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.h.... Accessed 4 December 2021.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous